Oramed Pharmaceuticals (ORMP) Institutional Ownership $2.15 -0.07 (-3.15%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$2.24 +0.10 (+4.42%) As of 02/21/2025 06:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Oramed Pharmaceuticals (NASDAQ:ORMP)CurrentInstitutional OwnershipPercentage12.73%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$6.61MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$3.08M Get ORMP Insider Trade Alerts Want to know when executives and insiders are buying or selling Oramed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ORMP Institutional Buying and Selling by Quarter Oramed Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Squarepoint Ops LLC54,439$132K0.0%-34.7%0.135% 2/17/2025 Two Sigma Investments LP110,378$267K0.0%-22.1%0.274% 2/17/2025 Two Sigma Advisers LP241,400$584K0.0%-5.6%0.599% 2/17/2025 Millennium Management LLC24,381$59K0.0%-47.8%0.060% 2/17/2025 Bank of America Corp DE167,653$406K0.0%-2.6%0.416% 2/14/2025 Jane Street Group LLC49,663$120K0.0%-14.8%0.123% 2/14/2025 Boothbay Fund Management LLC845,188$2.05M0.1%+2.0%2.097% 2/14/2025 Dimensional Fund Advisors LP118,995$288K0.0%+143.8%0.295% 2/13/2025 Renaissance Technologies LLC151,808$367K0.0%-38.1%0.377% 2/11/2025 LPL Financial LLC17,431$42K0.0%-54.9%0.043% Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/7/2025 BML Capital Management LLC2,643,907$6.40M4.0%+20.9%6.559% 2/4/2025 World Equity Group Inc.20,000$48K0.0%N/A0.050% 1/29/2025 Peapod Lane Capital LLC227,239$550K0.5%N/A0.564% 1/14/2025 Marquette Asset Management LLC33,311$81K0.0%N/A0.083% 11/15/2024 XTX Topco Ltd24,716$60K0.0%+59.7%0.061% 11/15/2024 Murchinson Ltd.1,708,879$4.17M1.1%+0.5%4.239% 11/8/2024 Connor Clark & Lunn Investment Management Ltd.111,519$272K0.0%N/A0.274% 11/5/2024 BML Capital Management LLC2,186,191$5.33M3.1%+62.1%5.362% 8/16/2024 Murchinson Ltd.1,699,990$4.37M0.7%+23.2%4.184% 8/14/2024 Squarepoint Ops LLC81,758$210K0.0%-8.3%0.201% 8/14/2024 Murchinson Ltd.874,992$2.25M0.4%-36.6%2.154% 8/12/2024 XTX Topco Ltd15,474$40K0.0%N/A0.038% 8/9/2024 Renaissance Technologies LLC230,800$593K0.0%+89.0%0.568% 8/9/2024 Dimensional Fund Advisors LP31,470$81K0.0%+52.1%0.077% 5/20/2024 Virtu Financial LLC23,165$68K0.0%N/A0.057% 5/16/2024 Murchinson Ltd.1,379,495$4.03M0.3%+31.4%3.395% 4/24/2024 Assenagon Asset Management S.A.18,659$54K0.0%N/A0.046% 4/23/2024 BML Capital Management LLC844,496$2.47M1.6%-33.1%2.084% 1/30/2024 BML Capital Management LLC1,261,559$2.91M2.2%+61.5%3.127% 11/13/2023 Algert Global LLC14,680$38K0.0%N/A0.036% 11/13/2023 Rathbones Group PLC289,803$756K0.0%N/A0.718% 11/7/2023 Barclays PLC18,406$47K0.0%+39.0%0.046% 11/6/2023 N.E.W. Advisory Services LLC12,960$34K0.0%N/A0.032% 10/23/2023 BML Capital Management LLC781,292$2.04M1.9%-8.1%1.940% 9/21/2023 Barclays PLC13,239$47K0.0%-35.9%0.033% 8/7/2023 Acadian Asset Management LLC31,736$113K0.0%N/A0.079% 7/26/2023 Glass Jacobson Investment Advisors llc12,255$44K0.0%N/A0.031% 7/24/2023 BML Capital Management LLC850,000$3.04M2.7%-37.3%2.123% 5/12/2023 Corsair Capital Management L.P.47,256$103K0.0%N/A0.119% 4/18/2023ETF Managers Group LLC68,940$150K0.0%N/A0.173% Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret.4/14/2023 BML Capital Management LLC1,355,925$2.96M2.6%N/A3.409% 2/14/2023 683 Capital Management LLC20,537$247K0.0%N/A0.052% 2/13/2023 GSA Capital Partners LLP46,039$554K0.1%N/A0.118% 2/9/2023 Landscape Capital Management L.L.C.26,220$315K0.0%N/A0.067% 2/9/2023 Citigroup Inc.65,890$793K0.0%+115.0%0.168% 2/8/2023 Belpointe Asset Management LLC29,900$360K0.0%N/A0.076% 2/8/2023 Russell Investments Group Ltd.56,516$680K0.0%N/A0.144% 2/6/2023 Glass Jacobson Investment Advisors llc9,350$112K0.1%N/A0.024% 2/1/2023 Private Portfolio Partners LLC53,600$645K0.2%-20.5%0.137% 2/1/2023 Janney Montgomery Scott LLC12,379$149K0.0%N/A0.032% 1/26/2023 Calamos Advisors LLC14,746$177K0.0%N/A0.038% 1/25/2023 Lindbrook Capital LLC383,351$4.61M0.6%N/A0.980% 1/18/2023 Private Advisor Group LLC11,794$142K0.0%N/A0.030% 11/15/2022ETF Managers Group LLC94,493$612K0.0%+8.2%0.242% 11/14/2022 Cubist Systematic Strategies LLC117,477$761K0.0%+66.1%0.303% 11/14/2022Ergoteles LLC24,149$156K0.0%-89.3%0.062% 11/10/2022 Phoenix Holdings Ltd.13,634$89K0.0%-73.2%0.035% 11/7/2022 Virtu Financial LLC21,526$139K0.0%-19.3%0.055% 11/7/2022 Private Portfolio Partners LLC67,400$437K0.1%+24.8%0.174% 11/3/2022 Barclays PLC21,543$140K0.0%+8.7%0.055% 10/31/2022 SG Americas Securities LLC10,370$67K0.0%-77.7%0.027% 10/21/2022Morgan Jess S & Co. Inc.366,401$2.37M2.1%+16.2%0.944% 10/17/2022 Cambridge Investment Research Advisors Inc.14,184$92K0.0%+26.8%0.037% 8/15/2022 Laurion Capital Management LP12,393$57K0.0%N/A0.032% 8/13/2022 Virtu Financial LLC26,661$122K0.0%N/A0.069% 8/11/2022 Bank of Montreal Can249,200$1.35M0.0%N/A0.646% 8/8/2022 Oppenheimer & Co. Inc.50,000$229K0.0%+5.4%0.130% 8/2/2022 Private Portfolio Partners LLC54,010$247K0.1%+27.8%0.140% 7/29/2022 SG Americas Securities LLC46,532$213K0.0%N/A0.121% 7/21/2022 Belvedere Trading LLC40,690$343K0.0%N/A0.106% 7/19/2022 Commonwealth Equity Services LLC29,514$135K0.0%+7.1%0.077% 7/18/2022Morgan Jess S & Co. Inc.315,301$1.44M1.5%+8.5%0.818% 7/13/2022 Cambridge Investment Research Advisors Inc.11,184$51K0.0%N/A0.029% 6/30/2022 Amalgamated Bank6,457$56K0.0%N/A0.017% 5/16/2022Morgan Jess S & Co. Inc.290,501$2.51M1.8%+34.9%0.759% 5/12/2022 Private Portfolio Partners LLC42,250$365K0.1%N/A0.110% 5/12/2022 Oppenheimer & Co. Inc.47,450$410K0.0%+18.6%0.124% 5/10/2022 Phoenix Holdings Ltd.28,155$244K0.0%-10.1%0.074% 5/9/2022 Rossmore Private Capital40,661$352K0.1%-21.8%0.106% 5/9/2022 Qube Research & Technologies Ltd56,348$487K0.0%-13.0%0.147% 5/5/2022 Russell Investments Group Ltd.43,013$371K0.0%-55.7%0.112% 5/3/2022 Calamos Advisors LLC38,071$330K0.0%-65.9%0.099% 4/25/2022 Assenagon Asset Management S.A.385,413$3.33M0.0%N/A1.007% 4/21/2022Strs Ohio5,400$46K0.0%-41.9%0.014% 3/3/2022 Walleye Capital LLC36,740$525K0.0%N/A0.096% 2/14/2022 Point72 Hong Kong Ltd2,132$30K0.0%N/A0.006% 2/14/2022ETF Managers Group LLC53,153$729K0.0%+6.5%0.139% 2/14/2022 Rockefeller Capital Management L.P.4,000$57K0.0%N/A0.010% 2/11/2022 Renaissance Technologies LLC203,200$2.90M0.0%N/A0.531% 2/10/2022 Qube Research & Technologies Ltd64,799$925K0.0%N/A0.169% Watch This Robotics Demo Before March 17th (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo…2/10/2022 OLD Mission Capital LLC38,691$553K0.0%N/A0.101% 2/10/2022 HighTower Advisors LLC14,000$199K0.0%-50.0%0.037% 2/10/2022 Connor Clark & Lunn Investment Management Ltd.50,786$725K0.0%+96.4%0.133% 2/9/2022 BNP Paribas Arbitrage SA20,266$289K0.0%+275.9%0.053% 2/9/2022 UMB Bank N A MO8,080$116K0.0%N/A0.021% 2/8/2022 Swiss National Bank64,400$920K0.0%N/A0.168% 2/8/2022 Northern Trust Corp243,125$3.47M0.0%+7.7%0.635% 2/7/2022 Victory Capital Management Inc.13,310$190K0.0%N/A0.035% 2/7/2022 SG Americas Securities LLC8,631$123K0.0%-36.3%0.023% 2/7/2022 Phoenix Holdings Ltd.31,328$439K0.0%+9.5%0.082% (Data available from 1/1/2016 forward) ORMP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ORMP shares? During the previous two years, 27 institutional investors and hedge funds held shares of Oramed Pharmaceuticals. The most heavily invested institutionals were BML Capital Management LLC ($6.40M), Murchinson Ltd. ($4.17M), Boothbay Fund Management LLC ($2.05M), Rathbones Group PLC ($756K), Two Sigma Advisers LP ($584K), Peapod Lane Capital LLC ($550K), and Bank of America Corp DE ($406K).Learn more on ORMP's institutional investors. What percentage of Oramed Pharmaceuticals stock is owned by institutional investors? 12.73% of Oramed Pharmaceuticals stock is owned by institutional investors. Learn more on ORMP's institutional investor holdings. Which institutional investors have been buying Oramed Pharmaceuticals stock? Of the 20 institutional investors that purchased Oramed Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($3.13M), Murchinson Ltd. ($658.88K), Rathbones Group PLC ($289.80K), Peapod Lane Capital LLC ($227.24K), Connor Clark & Lunn Investment Management Ltd. ($111.52K), Renaissance Technologies LLC ($108.70K), and Dimensional Fund Advisors LP ($80.96K). How much institutional buying is happening at Oramed Pharmaceuticals? Institutional investors have bought a total of 4,937,867 shares in the last 24 months. This purchase volume represents approximately $11.93M in transactions. Which Oramed Pharmaceuticals major shareholders have been selling company stock? Of the 11 institutional investors that sold Oramed Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BML Capital Management LLC ($991.70K), Murchinson Ltd. ($504.50K), Renaissance Technologies LLC ($93.49K), Squarepoint Ops LLC ($36.28K), Two Sigma Investments LP ($31.31K), Millennium Management LLC ($22.29K), and LPL Financial LLC ($21.25K). How much institutional selling is happening at Oramed Pharmaceuticals? Institutional investors have sold a total of 1,735,601 shares in the last 24 months. This volume of shares sold represents approximately $5.09M in transactions. Related Companies Atai Life Sciences Institutional Ownership Revance Therapeutics Institutional Ownership Prime Medicine Institutional Ownership Esperion Therapeutics Institutional Ownership REGENXBIO Institutional Ownership Tourmaline Bio Institutional Ownership MBX Biosciences Institutional Ownership Aurora Cannabis Institutional Ownership Terns Pharmaceuticals Institutional Ownership Foghorn Therapeutics Institutional Ownership This page (NASDAQ:ORMP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oramed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.